ClinicalTrials.gg

Program

QRL-101

A development code. Also written as “QRL-101 Dose A” and “QRL-101 Dose B”.

Its studies are mostly in Amyotrophic Lateral Sclerosis, led by QurAlis.

Furthest: phase 1, since Dec 19, 20226 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
QurAlis60 open or runningphase 1since Dec 19, 2022Dec 19, 2022none ahead

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Dec 19, 2022First study: phase 1 study in Healthy VolunteersFirst studyNCT05667779 · 88 enrolled · Netherlands
  2. Jul 29, 2024Phase 1 study in Healthy VolunteersNCT06532396 · 60 enrolled · Netherlands
  3. Nov 5, 20242 phase 1 studiesNCT06681441, NCT06714396
  4. Mar 5, 2025Phase 1 study in Healthy VolunteersNCT06877624 · 25 enrolled · Netherlands
  5. Feb 12, 2026Phase 1 study in Healthy Participant StudyNCT07421778 · 48 enrolled · Netherlands

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 6 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07421778Healthy Participant Study · Netherlands1CompletedAug 31, 202648
NCT06877624Healthy Volunteers · Netherlands1CompletedMay 15, 202525
NCT06714396Amyotrophic Lateral Sclerosis · Netherlands1CompletedAug 22, 202512
NCT06681441Healthy · Netherlands1CompletedDec 24, 202424
NCT06532396Healthy Volunteers · Netherlands1CompletedDec 20, 202460
NCT05667779Healthy Volunteers · Netherlands1CompletedDec 27, 202388

How it is read

Names in the registry

  • “QRL-101”, 5 entries
  • “QRL-101 Dose A”, 1 entry
  • “QRL-101 Dose B”, 1 entry

Codes read as this program: QRL101.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.